ABHD5, CTSS, IFI44, TXNIP, and the M10.2 protein synthesis module OAZ1 RPS12, (this time including HBB) were confirmed to significantly distinguish active GVHD, and RBM38 (A37, “erythroid” aggregate) was newly identified in this analysis (Figure 4A,B right panels). Here, ABHD5 is linked to graft versus host disease.